PlatformQ Health

OMEDLIVE


The 2018 ASCO Quality Care Symposium was held on September 28 and 29, 2018 in Phoenix, AZ, and PlatformQ Health was honored to present a poster session on the impact of online patient education for people with bladder cancer. Promoting Patient Engagement in Bladder Cancer (BC) Care through Education features insights on an online educational…

Read More >>


Follicular Lymphoma: Coordinating Care Through Team‐Based Strategies, a new educational program worth 1 AMA PRA Category 1 Credits™, is now available on demand. Find it here.  In the Western hemisphere, follicular lymphoma (FL) is the most common non-Hodgkin lymphoma (NHL). In the US in 2018, it is expected that approximately 74,680 new cases of NHL will be diagnosed…

Read More >>


On Wednesday, September 26 at 1:30pm ET, CancerCoachLive will be sharing a special program with The Leukemia & Lymphoma Society, designed for those managing Follicular Lymphoma and their families. The panel will include specialists from Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center. Send us your questions and save a spot for this virtual event.    Current statistics estimate that…

Read More >>


OMedLive, an online oncology learning channel from PlatformQ Health Education, will be in Chicago for the ASCO Annual Meeting from June 1-5. Our commitment to oncology practice and cancer care makes this one of the most exciting events for our team, because it gives us an opportunity to explain how we’re improving healthcare outcomes through…

Read More >>


Jeff Arnold, General Manager at PlatformQ Health, attended the latest meeting of the American Urological Association (AUA) in San Francisco. Arnold, who joined the PQH team earlier this year, was a natural choice to represent our team at the AUA meeting as he focuses on leveraging our platform to deliver outcomes-driven education in Urology, Uro-oncology,…

Read More >>


March 25 through March 31 marks National Physicians’ Week, a time dedicated to recognizing and thanking doctors for the sacrifices they make to take care of all of us. Doctors work tirelessly to help people when they are most in need, and in spite of the important role they play in our lives, they often…

Read More >>


According to the American Cancer Society, who offer the most recent data regarding cancer statistics in the U.S., an estimated 161,360 men were newly diagnosed with prostate cancer in 2017. In the same time period, over 26,000 men died from the disease. A man’s risk of developing prostate cancer at any point during his life…

Read More >>


February is shaping up to be a busy time on the PlatformQ Health network. This month’s live broadcasts include a panel discussion on the new Heart Failure Guidelines and information about the latest treatment strategies for schizophrenia, as well as programs with Association of Community Cancer Centers (ACCC) and Depression and Bipolar Support Alliance (DBSA)…

Read More >>


The patient sitting on the exam table was happy to be diagnosed with breast cancer. That may seem unbelievable, especially for a 41 year old mother of young children. However, she was lucky to be screened. She is of the age where current controversy exists whether she should have an annual mammogram or not. Fortunately, we…

Read More >>


The reality of male breast cancer This year, like past years, over four hundred men in the US will die from breast cancer. Despite this fact, many people are unaware that men can even develop breast cancer. While advocates have done a great job raising awareness for breast cancer, men are still largely ignored in…

Read More >>


By Linda Girgis MD As medical students and residents, we were taught to fear pancreatic cancer. As most people know, the cure rate is dismal and the majority of victims die within the first year of diagnosis. While this has been improving over the past years, the low five year survival rate persists. According to…

Read More >>



Colorectal cancer is the third leading cause of cancer death in the US. The American Cancer Society (ACS) reported that there will be over 95,000 new cases of colon cancer and over 39,000 cases of rectal cancer in the US in 2016.  Men have a 1 in 21 lifetime risk of developing colorectal cancer whereas…

Read More >>


This OMEDLIVE presentation is Part Two of a two-part series surrounding Pediatric Neuroblastomas. During the conversation, Dr. Jason Shohet and Jennifer Saggio, MSN, CRNP, CPON focus on the following areas: Overview of pathology and standard therapy for high-risk NB Required imaging and evaluations for the revised INRGSS system Overall treatment scheme, including recent proposed changes…

Read More >>


A recap of OMedLive’s online CME program, Immunotherapy: Shifting the Lung Cancer Treatment Paradigm, which aired live on November 3rd, 2016. According to the American Cancer Society, lung cancer is the leading cause of cancer deaths in most countries. In 2015, the US saw 221,000 new cases of lung cancer (13% of all cancer cases)…

Read More >>



Gastric cancer, also known as stomach cancer, remains an aggressive cancer around the globe. Over the past several decades, there has been a slight decrease in incidence, yet it remains the fourth most common cancer and the second deadliest across the world.  Some factors that are thought to be responsible for the declining incidence include…

Read More >>


While everyone is aware that breast cancer in woman exists, many do not know men can be similarly afflicted. Breast cancer in women has its own awareness month (October) and its own symbol of awareness, the pink ribbon. Breast cancer in men, on the other hand, do not even have treatments tailored to them but…

Read More >>



Melanoma accounts for less than two percent of all skin cancers but it is the cause of most skin cancer deaths. Just over 10,000 patients a year die from the disease. These sober statistics sparked a focus on new treatments to decrease mortality rates, such as BRAF and MEK inhibitors.  The FDA has approved two…

Read More >>



According to the American Cancer Society, there were approximately 221,000 new cases of lung cancer in the U.S. in 2015. These patients accounted for about 13% of all new cancers. Of those, nearly 85-to-90 percent are non-small cell lung cancer (NSCLC). In this offering from OMedLive, Drs. Panos Fidias and Mark Socinski address some of…

Read More >>


In March of 2015, the FDA approved the first biosimilar for use with American patients. In the next five years, the market is expected to expand to $60 billion in sales in the U.S. and $127 billion worldwide. On February 1st, from 10 am – noon, EST, OMedLive in partnership with ClinicalSeriesLive, will be presenting…

Read More >>


Drs. Wasif Saif and Bert H. O’Neil take on some of the most recently approved treatment methods for metastatic colo-rectal cancer (mCRC) and compare their efficacy, risks, and benefits against other treatments options — some in use for the past half-century. Colo-rectal cancer is the second leading cause of cancer death in the United States;…

Read More >>


In this OMedLive video, nurses Brenda Riske and Regina B. Butler discuss “optimizing outcomes in hemophilia treatment” from a nurse’s perspective. Hemophilia, a genetic bleeding disease, affects about 20,000 Americans and over 400,000 people worldwide. A rare and serious condition, it requires a vigilant medical team for optimal patient care. Brenda Riske, RN, MSN, MBA,…

Read More >>


In this continuing medical education video session, Dr. Tanios Bekaii-Saab tells us, “in the last 30 years, overall five-year relative survival rates increased for most cancers except for lung and pancreatic cancers, which have shown the least improvement.” In terms of mortality, pancreatic cancer is the fourth leading type of cancer death for both men…

Read More >>